`Q5124` Inj. byooviz, 0.1 mg

Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg

Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 10 units per day (practitioner), rationale: CMS Policy